Dr. Christos Chinopoulos obtained his MD and PhD from Semmelweis University, in Budapest, Hungary. He did his postdoc in Baltimore, Maryland, under the supervision of Dr. Gary Fiskum. Currently, he is an Associate Professor at the Department of Biochemistry and Molecular Biology of the Semmelweis Universit, and the project leader of the Reverse Phase Protein Assay (RPPA) facility, where his research interest and focus is cancer metabolism. The RPPA facility aims to quantitate the expression of all mitochondrial proteins in healthy and solid tumor samples. A strong concept in Dr. Chinopoulos’ research is that alterations in oncometabolism substantiated by changes in proteins expression 'rewiring' certain metabolic pathways provide an excellent opportunity for cancer-specific therapeutic intervention. Identifying those proteins involved in bioenergetic pathways that are up- or downregulated in order to serve the needs of neoplasia is crucial for beating cancer.